Aims: Hypoxia-induced adipokine release has been attributed mainly to HIF-1α. Here we investigate the role of intracellular calcium and NF-kB in the hypoxia-dependent release of leptin, VEGF, IL-6 and the hypoxia-induced inhibition of adiponectin release in human adipocytes. Main methods: We used intracellular calcium imaging to compare calcium status in preadipocytes and in adipocytes. We subjected both cell types to hypoxic conditions and measured the release of adipokines induced by hypoxia in the presence and absence of HIF-1α inhibitor YC-1, NF-κ B inhibitor SN50 and intracellular calcium chelator BAPTA-AM.
Introduction
The growing incidence of obesity represents a major challenge to healthcare providers and the public alike. Excess caloric intake is stored ectopically and in specialized adipocytes within adipose tissue depots. Based on their anatomical position, depots may give rise to different disease risk factors [1] . Aside from white (WAT), beige, and brown (BAT) adipocytes [2] fat depots contain preadipocytes [3] , fibroblasts [4] , macrophages and immune cells [3, 5] , adipose tissue stem cells [6] , endothelial and smooth muscle cells [7] and neuronal cells [8] . The proportions may differ in terms of species, anatomical position, age, gender, and metabolic status. These cells are embedded within an extracellular matrix (ECM) scaffold composed mainly of proteoglycans and fibrous tissue [9] . The fibrous tissue provides an external skeleton offering mechanical strength, composed predominantly of collagen IV, V, and VI, laminin, fibronectin and entactin [10, 11] . Adipose tissue ECM is maintained by balancing synthesis and degradation of its various components which are regulated by matrixins, growth factors, and cytokines [12] . Chronic low-grade inflammation is thought to be necessary for normal remodeling of adipose tissue [13] , but it also provides a link between obesity and the metabolic syndromes [14] . A disparity between the rates of adipose tissue growth and vascularity may result in local hypoperfusion, which generates an oxygen gradient and a relative hypoxic milieu within the growing adipose tissue [15, 16] . Hypoxia has been shown to dysregulate the expression and release of adipokines in human adipocytes [17] . This was associated with increased expression of the hypoxia-inducible factor 1 alpha (HIF-1α) early post hypoxic exposure [17] . However, HIF-1α-independent hypoxic response has also been demonstrated [18] .
[Ca ++ ] i is one of the major second messengers in a variety of cell types, with signals defined by both their amplitude (amplitude-modulated; AM) and/or frequency (frequency-modulated; FM). FM calcium signals (calcium oscillations) have been reported in relation to gene expression and differentiation in many cell types including preadipocytes [19] . Furthermore, increased [Ca ++ ] i can inhibit both murine and human adipocyte differentiation [20] [21] [22] . Hypoxia has been demonstrated to increase intracellular calcium [Ca ++ ] i in human endothelial cells [23, 24] and to alter its distribution in SH-SY5Y neuroblastoma cells [25] . The hypoxia-induced changes in [Ca ++ ] i were shown to be independent of HIF-1α in the epithelial cell line A549 [26] .
Here we show distinct differences in intracellular calcium [Ca ++ ] i oscillations and ROS generation between preadipocytes and adipocytes. These phenotypes were associated with aberrant mitochondrial morphology. We further confirm that hypoxia alone appears sufficient to modulate the release of inflammatory mediators from adipocytes independently of HIF-1α expression. We report that [Ca ++ ] i regulates the hypoxia-induced release of leptin, vascular endothelial growth factor (VEGF) and IL-6 but not adiponectin. Our data provide new insights on the role of calcium in adipocyte biology.
Materials and methods

Materials
Human subcutaneous preadipocyte cells (HPAd, cat.# 802s-05a. Lot:1895) isolated from healthy human adipose tissue were purchased from Cell Applications, Inc. (San Diego, CA, USA). Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM:F12), trypsin-EDTA, 10 × BlueJuice™ Gel Loading Buffer, oligo(dT), dNTP mix, SuperScript® II Reverse Transcriptase, pre-cast SDS-PAGE 4-12% BisTris gels, 20 × running buffer, 20 × transfer buffer, Mito Tracker® Red CMXROS, Fluo-4-AM, and BAPTA-AM were from Life Technology, Inc. (Grand Island, NY, USA). Fetal bovine serum (FBS), trypan blue, phosphate-buffered saline (PBS), isopropanol, Oil Red O, YC-1, TriReagent BD, IGEPAL, phenylmethanesulphonyl fluoride, chymostatin, leupeptin, antipan and pepstatin, were from Sigma-Aldrich (St. Louis, MO, USA). Primers against human LEP (Hs00174877_m1), ADIPOQ (Hs00605917_m1), VEGF (Hs00900055_m1), IL6 (Hs00985639_m1), and RNA18S (Hs99999901_s1) were from Applied Biosystems (Foster City, CA, USA). Antibodies to perilipin were obtained from abcam (Cambridge, UK). Preadipocyte suspensions were treated with pre-warmed adipocyte differentiation medium (ADM) containing PGM supplemented with SingleQuots™ (containing insulin, dexamethasone, indomethacin, and isobutyl-methylxanthine; Lonza), centrifuged, and re-suspended in the above medium. Aliquots of 2 ml (2 × 10 6 cells) were transferred to each well of 6-well plates and cultured as above for 14 days with medium change every 3 days. Adipocyte differentiation was followed by microscopic observation of lipid droplets, which appeared 4-5 days after initiation.
Differentiation of preadipocytes to adipocytes
Oil red O staining, immunostaining and transmission electron microscopy (TEM)
Oil red O (0.5% in isopropanol) was diluted with water and incubated with formaldehyde-fixed cells (3.7%) for 1 h at room temperature. Cells were washed with water and the stained fat droplets were visualized by light microscopy. For immunofluorescence, primary and secondary antibodies were used according to manufacturer's instruction. Cells were viewed under confocal laser scanning microscopy (CLSM, Zeiss META 510, or Zeiss YukoGawa spinning wheel systems, Zeiss, Germany). For TEM cells were fixed with 2.5% glutaraldehyde in cacodylate buffer (0.1 M, pH 7.4) for a minimum of 48 h. Osmication was performed using reduced osmium (1:1 mixture of 2% osmium tetroxide and 3% potassium ferrocyanide). After pre embedding in agar (1%), samples were dehydrated in ethanol series and embedded in epoxy resin. Thin sections (70 to 100 nm thickness) were collected on copper grids and contrasted with lead citrate. Imaging was performed using a transmission electron microscope (TEM) operating at 300 kV (Titan Cryo Twin, FEI Company, Hillsboro, OR). Images were recorded on a 4 k × 4 k CCD camera (Gatan Inc., Pleasanton, CA).
Calcium, ROS, and nitroblue tetrazolium (NBT) measurements
[Ca ++ ] i was measured in fluo-4-AM-loaded cells previously grown on coverslips, using a CLSM and Zeiss META 510 software. Briefly, coverslips containing fluo-4AM loaded cells were sandwiched between the magnetic plates of a purposely built coverslip holder mounted on a temperature controlled inverted microscope stage adaptor. Serial images were acquired at approximately 1 s intervals. The stimulus (bradykinin, 25 μM) was added during image acquisition and images were stored and subsequently analyzed using CLSM software (Zeiss META 510, Zeiss, Germany) and Volocity software (Perkin Elmer, UK). Changes in intensity were colour-coded so that warm colors indicate high changes and cold colors indicate low changes. Ratio changes were calculated by normalizing intensity changes (after background subtraction) to the averaged intensity of the first three images before adding the stimulus. Mitochondria were visualized with MitoTracker® Red CMXROS (2 μM, 5 min at 37°C) using a CLSM. For NBT measurements, cells were washed with PBS, incubated with the NBT solution for 30 min at 37°C, fixed for 10 min with 3.7% formaldehyde and viewed under a light microscope. Image intensities were determined using ImageJ software (NIH, Bethesda, MD, USA).
Hypoxic exposure
Hypoxia was induced by incubating the cells at 0.5-1.0% oxygen in a purposely built hypoxia chamber (Biospherix, Ltd., Parish, NY, USA) using a mixture of carbon dioxide (5.53%) and nitrogen. Briefly, on day 13 of differentiation, ADM was replaced with PGM containing insulin and dexamethasone, and the day after adipocytes were placed in the chamber for 24 or 48 h. Control cells were exposed to normoxic conditions (21% oxygen). Experiments were repeated by treating cells with the hypoxia-inducible factor-1α (HIF-1α) inhibitor YC-1 (100 μM), the NF-κB inhibitor SN50 (20 μM), the calcium chelator (BAPTA-AM, 1 μM) or ionomycin (3 μM). Total RNA and proteins were extracted from the adherent cells. Media bathing the cells under the various treatments were collected and frozen at −80°C for subsequent analysis. 
Measurements of secreted adipokines
Protein extraction
Total cellular proteins were extracted using RIPA buffer containing IGEPAL (1%), sodium deoxycholate (0.5%; BDH Chemicals, Poole, UK), SDS (0.1%), NaCl (150 μM), and Tris pH 8 (50 μM), cathepsin L-associated protein (CLAP) (10 mM), leupeptin, antipan, and pepstatin (1 mM). Cells were collected, vortexed, placed on ice for 20 min, homogenized with a polytron (Amp 50%), and centrifuged at 9600 g for 20 min at 4°C. Supernatants were collected and stored at −80°C for further analysis.
RNA preparation and reverse transcription
Cells were lysed directly in the culture plate using Tri-Reagent BD according to manufacturer's instructions. The concentration of the RNA pellet was determined using NanoDrop-1000 spectrometer (Wilmington, DE, USA). A TaqMan® Universal PCR Master Mix (Applied Biosystems) containing DTT (100 mM), dNTP mix (10 mM), and SuperScript® II Reverse Transcriptase was multiplexed with RNA18S on CFX96 96-well plates (Bio-Rad). Each reaction was carried out in triplicate. Serial dilutions of the cDNA sample were used to obtain a standard curve. The plates were centrifuged briefly (Mini Plate Spinner-MPS 1000; Labnet, Woodbridge, NJ, USA) and run for 50 cycles in the CFX96 real-time (RT)-PCR system.
Statistical analysis
Differences between groups were measured using unpaired twotailed Student's t-test. A p-value of ≤0.05 was considered significant. One-way analysis of variance (ANOVA) with Sidak's multiple comparison post hoc test was used when appropriate (Prism 7 for Windows GraphPad Software, Inc).
Results
Adipocyte differentiation and mitochondrial changes
Preadipocytes exhibited time-dependent changes in morphology following differentiation in ADM. Cells accumulated fat in distinct droplets throughout the cytosol (Fig. 1A) . Small droplets coalesced into larger ones as cells matured. Differentiated cells presented variously sized multilocular droplets surrounded by membranes containing perilipin (Fig. 1B&C) . The mitochondria in differentiated cells were 'squeezed' between fat droplets (Fig. 1B&C ). Differentiated cells exhibited lower mitochondrial mass/function than preadipocytes as measured by MitoTracker® Red CMXROS fluorescence intensity (Supplementary Fig. 1A ). Transmission electron microscopy revealed mitochondrial swelling with degenerated cristae in differentiated cell in contrast to the preadipocyte healthy mitochondria (Fig. 1D&E) (Fig. 2B ). Differences in calcium handling were also seen in response to the Ca ++ -ATPase inhibitor thapsigargin before and after differentiation. The rise in calcium triggered by thapsigargin was significantly lower in adipocytes compared to preadipocytes (Fig. 2C&D) . Interestingly, the ratio of nuclear to cytosolic calcium changes was 1.20 ± 0.03 in preadipocytes compared to 1.04 ± 0.02 (p = 0.002) in adipocytes, where changes were observed sporadically around lipid droplets only. Interestingly however, chelating intracellular calcium by BAPTA-AM treatment inhibited preadipocyte to adipocyte differentiation in a dose dependent manner ( Supplementary Fig. 1C ).
Adipokine secretion in preadipocytes and adipocytes
Adipokine profiles were determined in bathing media of preadipocytes and adipocytes after 48 h of culture. Out of 44 different adipokines, 10 showed reproducible and statistically significant changes (Supplementary Table 1 ). IL-6, growth related oncogene (GRO), plasminogen activator inhibitor (PAI)-1, and nerve growth factor (NGF) were significantly reduced whereas VEGF-A, hepatocyte growth factor (HGF), leptin, and adiponectin were significantly increased as the cells transitioned from preadipocytes to adipocytes. In addition, although ADM contained dexamethasone, indomethacin and isobutyle-methylxanthine, the levels of inflammatory mediators monocyte chemoattractant protein-1 (MCP-1) and IL-8 were significantly higher in adipocytes than in preadipocytes.
Effect of hypoxia on adipokine secretion
In the absence of any other stimulus, exposure of preadipocytes to hypoxia for 24 h had no significant effect on the leptin levels released in the bathing medium. However, exposure to hypoxia for 48 h raised leptin levels to 85.7 ± 3.4 pg ml −1 per 10 6 cells compared to the levels under normoxic conditions (3 ± 1 pg ml −1 per 10 6 ) (Fig. 3A) . Exposure (24 and 48 h) of adipocytes to hypoxia raised leptin levels to 15,871 ± 1120 and 25,874 ± 1111 pg ml −1 per 10 6 cells respectively compared to the levels under normoxia which were 5654 ± 364 and 4548 ± 1402 pg ml −1 per 10 6 cells at 24 h and 48 h respectively (Fig. 3A) . Interestingly, VEGF-A levels were significantly induced in adipocytes under hypoxic conditions, reaching a maximum of 178 ± 12 (24 h) and 433 ± 91 (48 h) pg ml −1 per 10 6 cells. No significant effect of hypoxia on the VEGF-A levels in preadipocytes was observed (Fig. 3A) . Although the levels of IL-6 were several orders of magnitude higher in preadipocytes, hypoxic exposure had no significant effect on these levels. In contrast, the levels of IL-6 in adipocytes were considerably lower but with significant (p = 0.007) effect of hypoxia with maximum levels occurring at 48 h of exposure to hypoxia. IL-6 release increased in hypoxic adipocytes to 131 ± 14 and 239 ± 33 pg ml −1 per 10 6 cell after 24 and 48 h respectively from the normoxic levels of 61 ± 11 and 110 ± 13 pg ml cells) (Fig. 3A) . Hypoxia had no effect on adiponectin levels in preadipocytes, which were several orders of magnitude lower than the levels measured in adipocytes. To ascertain whether these changes were mirrored by changes in the mRNA levels, we measured the mRNA expression levels under normoxic and hypoxic conditions in adipocytes. mRNA levels for leptin and VEGF-A exhibited similar changes to the protein levels (Fig. 3B) . On the other hand, IL-6 mRNA levels initially decreased at 24 h (p < 0.002) but increased at 48 h of hypoxia ((p < 0.0001), Fig. 3B ). Adiponectin mRNA levels were unchanged at 24 h but increased significantly at 48 h of hypoxia (p < 0.0001, Fig. 3B ) when the protein levels were significantly lower than that under normoxic conditions.
Effect of HIF-1α and NF-κB inhibitors on the hypoxia-induced adipokine secretion
Because the effect of hypoxia was mainly on the adipocytes we continued by investigating the involvement of HIF-1α in hypoxia-induced adipokine release from the adipocytes. Direct measurement of HIF-1α using RT-PCR demonstrated a significant hypoxia-induced increase of HIF-1α mRNA that was inhibited by the HIF-1α inhibitor YC-1 [27] (Fig. 4A) . Further investigations using the HIF-1α inhibitor demonstrated that YC-1 failed to reverse the effect of hypoxia on leptin, VEGF-A, IL-6 or adiponectin secretion (Fig. 4B) suggesting a HIF-1α-independent mechanism(s). Given that hypoxia is associated with ROS production [28] we measured ROS using the NBT assay and report significantly higher levels of ROS in adipocytes than preadipocytes, particularly under hypoxic conditions (p < 0.003) (Fig. 4C) . Since ROS is intimately involved with the activation of NF-κB [29] we have investigated the effect of NF-κB inhibitor (SN50) on adipokine levels following hypoxic insult. In our hand, we found no significant effect on hypoxia-induced changes to leptin, VEGF-A and IL-6 however SN50 reversed the hypoxia-induced inhibition of adiponectin release and enhanced its secretion significantly (Fig. 4D) . In order to ascertain that NF-κB inhibitor SN50 was "working" we measured its effect on the expression of NF-κB p65 mRNA under normoxic and hypoxic conditions. We found that hypoxia induced NF-κB p65 that was inhibited by SN50 (see Fig. 1 B&C in Ref # [82] ). 
Effect of calcium on the hypoxia-induced adipokine secretion
Given the anti-adipogenic effect of calcium on preadipocyte differentiation [20, 21, 30] , we tested its involvement in the hypoxia-induced secretion of adipokines in differentiated adipocytes. We found that manipulating [Ca ++ ] i had varying effects (Fig. 5) .
with BAPTA-AM significantly augmented hypoxia-induced leptin and VEGF-A release at the protein (Fig. 5 ) and the mRNA levels (see Fig. 1A in Ref # [82] 
Discussion
The existence of distinct adipocyte precursors is suggested by the chronological appearance of WAT in different depots during development. It is thought that fusiform mesenchymal precursor cells give rise to preadipocytes, which are the early epitheloid 'lipoblasts'. In humans, this occurs at prenatal week 14-16, week 23, and early postnatal period [31] . Several reports have described the induction of fibroblasts into proliferating preadipocytes, which then differentiate into adipocytes through a variety of soluble stimuli, particularly insulin [32] . Moreover, mature adipocytes display certain plasticity towards de-differentiation into proliferating fibroblast-like cells that are capable of redifferentiating back into adipocytes [33] . Adipose-derived stem cells [34] , mesenchymal stem cells [35, 36] and cells derived from the stromal vascular fraction [37, 38] can differentiate into adipocytes. Here, we have investigated the differentiation of human subcutaneous preadipocytes (HPAd) into adipocytes and found that an anti-inflammatory 'environment' favoured the accumulation of fat in droplets. The latter may suggest inhibition of lipolysis and reduced expression of lipolytic parameters. This may be supported by the work of Ritter et al. who reported an increase in lipolysis during acute inflammation in a randomized cross over human trial [39] . On the other hand, a role for inflammation in adipose tissue expansion was demonstrated in animal models which failed to expand their adipose tissue due to an inability to mount a pro-inflammatory response [13] .
One interesting transition observed as preadipocytes differentiated into adipocytes was related to the state of the mitochondria. Whereas preadipocytes contained mitochondria with normal rod and tubular morphology typical of healthy cells, in adipocytes the mitochondria appeared swollen with considerable loss of cristae. It is argued that conversion of preadipocytes to adipocytes is a normal physiological process and that the two cell types are expected to have differences including mitochondrial changes. Though true, the adipocyte mitochondria appeared swollen with clear loss of cristae suggesting an aberrant morphology rather than differences due to different cell types. Loss of cristae and mitochondrial swelling is associated with a number of neuropathies and myopathies [40, 41] . It is also associated with glycogen storage disease where mitochondrial membrane potential is compromised, oxidative phosphorylation is impaired and mitochondrial biogenesis is reduced [42] . Mitochondria play a pivotal role in regulating ROS production [43] and are thought to act as a sink for externally added ROS, keeping the cellular signaling microdomain in check [44] . The mitochondria generate around 12 nmol of superoxide per min per g wet weight [45, 46] suggesting a tightly controlled redox buffering capacity. ROS have been demonstrated to reversibly inhibit mitochondrial respiration and two key mitochondrial dehydrogenases (alpha-ketoglutarate dehydrogenase and succinate dehydrogenase) [47, 48] . In addition, ROS was shown to alter NADH/FAD ratio and to inhibit mitochondrial bioenergetics [49] . In this manuscript, we demonstrate a significant increase in ROS production in differentiated cells compared to preadipocytes. attributed the intracellular calcium oscillations in preadipocytes to calcium influx through the L-type calcium channels, store operated calcium channels (SOC), IP3R-and SERCA-modulated activities [19] . Since mitochondria shape intracellular calcium changes including calcium oscillation, it would not be surprising that the significantly reduced oscillations observed in adipocytes and the dysregulated nuclear to cytosolic [Ca ++ ] i ratios are a consequence of the aberrant status of mitochondria in the differentiated cells. The link between calcium signaling and mitochondrial morphology was demonstrated in human disorders affecting brain and muscle where mitochondrial network was severely fragmented in patients carrying mutations in mitochondrial calcium uniporter associated proteins [51, 52] . Furthermore Deheshi et al. have demonstrated mitochondrial remodeling in response to calcium changes that has been linked to ROS production [53] . It is noteworthy that differentiation of 3T3-L1 preadipocytes to adipocytes was shown to be associated with mitochondrial biogenesis [54] and dysfunction during differentiation [55] . Mitochondrial biogenesis is very tightly controlled. Damaged mitochondria are cleared by mitochondrial autophagy. Fission and fusion of mitochondria are intimately linked to mitochondria-associated ER membranes (MAMs). MAMs, described as contact milieu between ER and mitochondria where molecular information including calcium, ROS and mediators of lipid metabolism are exchanged. Intramitochondrial calcium [Ca ++ ] mito is controlled by several mechanisms including the mitochondrial permeability transition pore (mPTP), the opening of which is linked to ROS and to aberrant calcium homeostasis [44] . Both increased ROS and aberrant calcium homeostasis were presented in this manuscript. Prolonged opening of mPTP leads to dissipation of mitochondrial membrane potential thus uncoupling of ATP synthesis from oxidative phosphorylation and mitochondrial swelling [56] . The mitochondrial swelling we reported above may therefore be a consequence of mPTP opening due to increased ROS production and aberrant calcium homeostasis in the adipocytes.
Interactions between ER and mitochondria are regulated by a number of chaperones and the mitochondria shaping proteins [57] . Bidirectional coupling of Ca++ between the ER and the mitochondria is necessary for normal calcium homeostasis and energy metabolism [58] . Appropriate ER-mitochondrial coupling promotes respiration and is necessary for maintaining glucose homeostasis [58] . Although the status of ER was not investigated in this manuscript, it is tempting to speculate that ER will also be adversely affected because of transition from preadipocytes to adipocytes. The question as to whether browning of white adipocytes reverses the mitochondria and ER states in the white adipocytes is yet to be determined.
The association between chronic low-grade inflammation and obesity has been reported in many animal and human studies [5, [59] [60] [61] [62] . Diabesity (obesity and diabetes) is intimately linked to hypoxia, oxidative stress and inflammation [63] . Adipose tissue hypoxia may underlie the pathophysiology of chronic low-grade inflammation observed in obesity and associated metabolic events [16, 17, 64] . Hyperoxia has been advocated as a potential therapeutic approach in managing obesity with some "reservations" regarding the deleterious effect of elevated oxygen levels on cellular homeostasis [65] . Moreover, increased serum calcium levels have been reported as a risk factor in type 2 diabetes in a number of human and animal studies [66] [67] [68] [69] . Although recruitment and polarization of macrophages (as the cause of inflammation) have been observed in vivo, adipocytes have been shown to produce inflammatory mediators in the absence of macrophages [17, 70, 71] . Here, we show that preadipocytes express a number of adipokines, including IL-6, GRO, PAI, and NGF at significantly higher levels than adipocytes. The reverse is true for IL-8, MCP-1, leptin, adiponectin, HGF, and VEGF-A. Presumably, the former expression profile is necessary for preadipocyte proliferation, whereas the latter may be necessary for adipogenesis. Our data confirm previous reports demonstrating that adipose tissue secrete a large number of adipokines [17, 25, 72] and suggest that the release of inflammatory mediators may recruit circulating inflammatory cells (eg. monocytes) to the fat depot to exacerbate the inflammatory response. In this study, we further confirm that hypoxia alone is sufficient to induce the release of inflammatory mediators such as leptin, VEGF-A, IL-6 and suppress adiponectin secretion from adipocytes [23] [24] [25] . Because responses to hypoxia are mediated by a number of mechanisms including HIF-1α-dependent mechanism, we measured adipocytes' HIF-1α under hypoxic and normoxic conditions. Although a significant increase in HIF-1α was evident following hypoxic insult, inhibition of hypoxia-induced HIF-1α by YC-1 failed to inhibit the hypoxia-induced leptin, VEGF-A, IL-6 and adiponectin changes suggesting an HIF-1α-independent hypoxia response in these cells. A number of studies have suggested the existence of HIF-1α-independent hypoxia response [18, 26, 73] . Priyanka et al. [74] have demonstrated that inhibition of NF-k B/JNK activation inhibited hypoxia-induced adipokine secretion. Furthermore, Salnikow et al. [26] have demonstrated a calcium, c-Jun/ AP-1-dependent hypoxic response in A549 cells. Since (i) adipocytes exhibited elevated levels of ROS and (ii) NF-k B activation is known to be modulated by ROS [29] , we used a pharmacological inhibitor of NF-k B to test its effect(s) on the hypoxia-induced adipokine secretion. Our data demonstrate the failure of NF-k B inhibition to reverse the hypoxia-induced release of leptin, VEGF-A and IL-6 suggesting an NF-k B-independent hypoxia response. Interestingly however, hypoxiainduced inhibition of adiponectin secretion was reversed with significant enhancement of its release induced by the NF-k B inhibitor. hypoxia-induced IL-6 release is controlled. IL-6 has been demonstrated to reduce mitochondrial respiration in adipocytes [78] . Whether the hypoxia-induced IL-6 release reported here directly influenced mitochondrial function remains to be determined. The role of [Ca
++
] i in adiponectin release following hypoxic insult is not well defined. Kappes and Loffler [79] have reported increased release of adiponectin in response to ionomycin dose dependently, under normoxic conditions. Conversely, Komai et al. [80] demonstrated that adiponectin release occurred in cAMP/Epac-dependent but [Ca ++ ] i independent manner, again under normoxic condition. Our data demonstrate that the hypoxia-induced inhibition of adiponectin secretion was calcium-independent.
In conclusion, our findings demonstrate significant differences in mitochondrial morphology, calcium and ROS status following preadipocytes differentiation to adipocytes. Furthermore, the effect of hypoxia was more pronounced in adipocytes than preadipocytes and hypoxia-induced adipokine secretion occurs through multiple secretory pathways depending on the adipokine. Whereas all four measured adipokines were HIF-1α-independent, adiponectin was NF-κ B -dependent and VEGF-A and leptin were [Ca ++ ] i -dependent. IL-6 release on the other hand was controlled through a narrow range of calcium perhaps through [Ca ++ ] i set point similar to that occurring in other cell types [81] . More studies on [Ca ++ ] i and mitochondrial function may pave the way towards a better understanding of adipocyte biology. Finally, since this work was performed with subcutaneous preadipocytes/adipocytes, it would be of interest to conduct similar studies using cells isolated from different depots, for example visceral preadipocytes/adipocytes for comparative studies.
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